This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

Event Date: 10/29/2019
Location: Jefferson, AR
Subject: National Center for Toxicological Research (NCTR) Laboratory Ribbon Cutting Ceremony
FDA Participant/Group: Several FDA staff attended
Non FDA Participant/Group: Government, state officials, and other invited guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 10/29/2019
Location: Las Vegas, NV
Subject: HLTH (Create Health's Future) Summit 2019
FDA Participant/Group: MATTHEW DIAMOND;
Non FDA Participant/Group: Attendees from industry, academia, government, and the media

Event Date: 11/01/2019
Location: Boca Raton, FL
Subject: CNS (Collaborating for Novel Solutions) Summit 2019
FDA Participant/Group: BAKUL PATEL;
Non FDA Participant/Group: Attendees from industry, academia, government, and the media

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/29/2019
Location: Beijing, China
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LATASHA ROBINSON; LIXIA WANG; JULIO SALAZAR; ADRIANNE FUENTES;
Non FDA Participant/Group: Jinjing ZHANG, Qi LIU, Shiyuan DONG, Xiangzhang LI, Xiaoyu LI, Yaqi LI (State Administration for Market Supervision of the People’s Republic of China);

Event Date: 10/30/2019
Location: Beijing, China
Subject: China International Food Safety and Quality Conference
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Members from the food industry, academia, government, and the media

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

Event Date: 10/28/2019
Location: Silver Spring, MD
Subject: Pharmavite LLC Listening Session
FDA Participant/Group: STEVEN TAVE; MELISSA ROBB; SHARON MAYL; APRIL ALEXANDROW; REBECCA GOLDBERG; JOSEPH FRANKLIN; ALISON THOMPSON; RACHEL OSTERMAN; CARA WELCH;
Non FDA Participant/Group: Christine N. Burdick-Bell, Ingrid Lebert, Peter Reinecke (Pharmavite LLC);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/29/2019
Location: Washington, DC
Subject: Milken Institute Conference: Flipping the Script: Designing the System to Deliver for Patients Panel
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, government, and the media

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event